Grant: Project Grant
University of Alberta
$755,440.00
Novel protective roles for ATP-sensitive potassium channels in the heart
EF 2017-18
Résumé
ATP-sensitive potassium channels play an important role in protecting the heart from damage during ischemic heart disease. Our recent results suggest these channels may also play an important role in the appropriate regulation of heart function prior to any disease and that
certain commonly used anti-diabetic drugs that target this channel may increase the incidence of certain types of heart disease. This research is aimed at finding the precise mechanisms by which these channels provide protection to the heart as well as determine which anti-diabetic drugs may place a patient at increased risk of heart disease.
Programme
Project Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
379689
Name
Light Peter E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - A: Cells and Tissues
Projecttitle
Novel protective roles for ATP-sensitive potassium channels in the heart
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$755,440
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Electrophysiology; Heart; Heart Failure; Ischemic Heart Disease; Katp Channels; Metabolism; Sulfonylureas
Abstract
ATP-sensitive potassium channels play an important role in protecting the heart from damage during ischemic heart disease. Our recent results suggest these channels may also play an important role in the appropriate regulation of heart function prior to any disease and that
certain commonly used anti-diabetic drugs that target this channel may increase the incidence of certain types of heart disease. This research is aimed at finding the precise mechanisms by which these channels provide protection to the heart as well as determine which anti-diabetic drugs may place a patient at increased risk of heart disease.
Competitiondate
201803
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Light, Peter E
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $755,440~ $0~